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INTRODUCTION
An association between depression and altered immunity
has been suggested by many research groups (1, 2), although
immunological findings have not been consistently demon-
strated. Immune changes associated with depression include
decreased mitogen-induced lymphocyte proliferation and nat-
ural killer (NK) cell activity, and enumerative changes like
increases in the total number of white blood cells and neutro-
phils, and a reduction in the number of lymphocytes (2, 3).
Recently, depression is also thought to be associated with acti-
vation of some aspects of cellular immunity increasing secre-
tion of proinflammatory cytokines such as interleukin-1, inter-
leukin-6, and tumor necrosis factor-alpha that can elicit depres-
sive or anxiety symptoms, as contrasted with the initial opin-
ion that depression can compromise immune system (4, 5).
Patients experiencing a major depressive episode along with
a comorbid panic disorder have a greater number of T cells,
and more mitogen-induced lymphocyte proliferation than
depressed patients without panic disorder (6). Panic disorder
comorbidity seems to contribute to immune variances in pa-
tients with major depressive disorder, and it seems reasonable
to postulate that some immunological alterations may be
attributed to panic disorder. However, relatively few studies
have been carried out to observe immune changes in panic
disorder, and these studies do not reveal any consistent immu-
nological differences for panic disorder patients versus normal
subjects. Marazziti et al. (7) showed that panic disorder pati-
ents do not differ from healthy controls in immune cell num-
ber, except for T helper (Th) cells, which were significantly
lowered. However, many other studies reported no differences
in the numbers and proportions of immunocytes in panic dis-
order without concurrent depression (8-10). In addition, some
studies have indicated that B-cell numbers are altered in panic
disorder patients, although not all in the same direction (10-
12).
We postulated that panic disorder patients have altered
immunity versus normal healthy subjects, and thus we exam-
ined differences in lymphocyte subset counts between panic
disorder patients and control subjects. We also tried to identify
the relationship between clinical variables including mood
states, and lymphocyte subsets in panic disorder patients.
MATERIALS AND METHODS
All subjects were medically healthy ones, and they included
20 panic disorder patients and 20 age- and gender-matched
normal control subjects (10 males and 10 females in each
group). The panic disorder patients who had other major
psychiatric disorders including other anxiety disorders, major
depressive disorder, and substance abuse were excluded from
this study. The patients were new outpatients who had vis-
ited the Samsung Medical Center in Seoul, and all met the
DSM-IV criteria for panic disorder using the Anxiety Dis-
order Interview Schedule for DSM-IV (13). Patients were
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Lymphocyte Subsets and Mood States in Panic Disorder Patients
This study was conducted to examine lymphocyte subset counts and mood states
in panic disorder patients. Twenty patients with panic disorder and 20 age- and gen-
der-matched normal healthy subjects were recruited for the study. We used the Spiel-
berger State (STAIS) & Trait (STAIT) Anxiety Inventory, Hamilton Depression Rat-
ing scale (HAMD) and Hamilton Anxiety Rating scale (HAMA) to measure mood
states in all subjects. Lymphocyte subsets counts were made by flow cytometry.
Panic patients showed significantly higher scores for anxiety and depression than
normal subjects. Panic patients showed no differences in terms of the numbers of
immune cells, as compared with normal healthy subjects, other than a lower propor-
tion of T suppressor cells and a higher T helper cell/T suppressor cell ratio. HAMA
and STAIS scores were common factors that could predict T cell numbers and pro-
portions, T helper cell numbers, and natural killer cell proportions in panic disorder
patients. We suggest that anxiety levels are related to the T-cell population in panic
disorder patients and that quantitative immune differences may reflect altered immu-
nity in this disorder. 
Key Words : Panic Disorder; Lymphocyte Subsets; Immunity; Anxiety; Test Anxiety Scale
Received : 1 October 2004
Accepted : 24 November 2004216 J.-E. Park, S.-W. Kim, Q Park, et al.
not receiving any regular anti-panic medication at the time
of study, although some of the patients took alprazolam inter-
mittently at the time of study, but had never received any
treatment for panic disorder previously. They had a relatively
recent onset of illness (38.5±50.3 weeks), and 17 among
20 panic patients showed less than 1 yr of illness duration.
Physical examinations were performed with comprehen-
sive history taking and some clinical laboratory tests (EKG,
and liver function and thyroid function testing) so as to exclude
panic symptoms secondary to other medical conditions. Heal-
thy age- and gender-matched controls were recruited through
an internet advertisement in Seoul. All subjects were required
to be in good health, and this was defined as having no acute
or chronic medical or psychiatric illness that could affect im-
munity (2, 14-17). Control subjects did not take any medi-
cation known to affect the immune system.
The Institutional Review Board of Samsung Medical Center
approved the study protocol, and a written informed consent
was obtained from all subjects after the procedures had been
fully explained. Background data were collected, including
demographic data and medical and psychiatric histories. Body
Mass Index (BMI), which might affect immune function, was
calculated as weight in kilograms divided by height in meters
squared; BMIs ranged from 18 to 30 among all 40 subjects.
Subjects were instructed to fast for 12 hr prior to the study
and to refrain from caffeinated beverages, alcohol, and smok-
ing for 24 hr prior to the study. We began the study at 8 a.m.,
and upon arrival, a 20-gauge catheter was inserted into a fore-
arm vein. After a physical examination and blood pressure
monitoring, subjects were quietly rested for 30 min. At the
end of this period, blood samples were collected. Four milli-
liters of blood was drawn initially and discarded and then at
least 3 milliliters was drawn into an EDTA tube. The total
white blood cell count and the differential count were obtained
using a Coulter GEN-S hematology analyzer (Beckman Coul-
ter, Inc., Fullerton, CA, U.S.A.). Whole blood samples were
first stained with Simultest LeucoGATE, Control, and CD3/
CD19, CD3/CD4, CD3/CD8, and CD3/CD16+CD56 rea-
gents (BD Immunocytometry Systems, San Jose, CA, U.S.A.).
Diluted FACS Lysing Solution (BD Immunocytometry Sys-
tems) was then used to lyse the red blood cells and stain. After
appropriate washing and suspending, the cells were analyzed
using a FACSort flow cytometer (BD Immunocytometry
Systems). Gates were selected using forward and right angle
light scatter and a minimum of 1,000 cells were included
in each analysis. The instrument’s photomultiplier tube volt-
ages, fluorescence compensation levels, and sensitivity were
always checked on the day of the analysis. After each of the
subset proportions was enumerated from a two-color dot plot,
absolute counts were calculated. 
Psychological evaluations were done on all subjects on the
same day of blood sampling. Anxiety symptoms were assessed
using the Korean version of the Spielberger Trait (STAIT) &
State (STAIS) Anxiety Inventory (18) and the Hamilton Anx-
iety Rating Scale (HAMA) (19), and depressive symptoms
were assessed using the 17-item Hamilton Depression Rat-
ing Scale (HAMD) (20).
To compare immunological and psychological variables
between panic patients and control subjects, independent t-
tests were used. Pearson correlation analyses were done to assess
whether clinical variables including anxiety or depressive levels
are associated with immunologic alterations in patients with
panic disorder. Stepwise multiple regression analyses were
used to identify predictors of immune variables in panic dis-
order. All analyses were performed using SPSS 11.0 statisti-
cal software. 
RESULTS
The characteristics of panic disorder patients and control
subjects are shown in Table 1. No significant differences were
evident with respect to age, sex, or BMI between the two gro-
ups. Panic disorder patients had significantly higher HAMA,
HAMD, STAIS and STAIT scores than control subjects.
The patients with panic disorder had a lower T suppressor
(Ts) cell proportion (t=2.63, p=0.012) and a higher Th/Ts ratio
(t=-2.57, p=0.014), than controls. Total WBC number (t=
-1.85, p=0.072) was slightly higher in panic disorder patients,
but this did not reach statistical significance (Table 2).
Ten panic patients with a HAMD score of >17 had a lower
BMI (p=0.031) than 10 panic disorder patients with a HAMD
score of <17. More depressive panic patients had lower num-
bers (p=0.036) and proportions (p=0.013) of NK cell, but
showed no differences with respect to other cumulative im-
mune variables versus less depressive panic disorder patients.
Age, gender, and BMI showed no association with immune
variables. For panic disorder patients, HAMA scores were
positively correlated with T cell number (r=0.498, p=0.025),
T cell proportion (r=0.495, p=0.026), and Th cell number
(r=0.444, p=0.050), but HAMA scores correlated negatively
with NK cell proportion (r=-0.529, p=0.016). STAIS scores
for panic disorder patients showed a significant positive cor-
BMI, Body Mass Index; HAMD, Hamilton Depression Rating Scale; HAMA,
Hamilton Anxiety Rating Scale; STAIS, State Trait Anxiety Inventory-State
form; STAIT, State Trait Anxiety Inventory-Trait form.
*, p<0.01.
Variable t p Value
Control subjects
n=20 (Male=10)
Mean SD
Panic patients
n=20 (Male=10)
Mean SD
Age (yr) 32.4 4.5 34.9 7.0 -1.37 0.180
BMI (kg/m
2) 22.1 1.8 21.8 3.1 0.38 0.704
HAMD 3.3 2.8 17.0 6.8 -8.36 <0.01*
HAMA 4.5 3.0 22.0 10.1 -7.26 <0.01*
STAIS 37.3 8.9 48.7 9.5 -3.81 <0.01*
STAIT 41.2 11.0 51.7 8.3 -3.31 <0.01*
Table 1. Characteristics of panic patients and control subjectsLymphocyte Subsets in Panic Disorder 217
relation with T cell proportion (r=0.533, p=0.023), and a neg-
ative correlation trend was noted between STAIS scores and
NK cell proportion (r=-0.467, p=0.051). However, HAMD
scores significantly negatively correlated with NK cell pro-
portion (r=-0.449, p=0.047). 
Stepwise multiple regression analyses were done to identify
the clinical predictors of immune variable in panic disorder
patients (Table 3). HAMA scores predicted T cell number
(R2=0.296, p=0.020), Th cell number (R2=0.230, p=0.044),
and NK cell proportion (R2=0.243, p=0.038), whereas STAIS
scores predicted T cell proportion (R2=0.284, p=0.023). How-
ever, other clinical variables, including the level of depression,
were not found to predict any immune parameter.
DISCUSSION
We found that panic disorder patients exhibited no differ-
ences with respect to the absolute number of immune cells,
except for a reduced proportion of Ts cells and an increased
Th/Ts ratio, as compared with normal healthy subjects. Mara-
zziti et al. (7) reported significantly fewer Th cells and reduced
Th/Ts ratios in panic disorder patients, and others have found
increases (11, 12) or decreases (21) in B cell populations in
panic disorder. However, our findings support a lack of a rela-
tion between this disorder and the absolute numbers of Th
cells (9-12, 21), the B cells (7, 9), and NK cell (9, 10, 12, 21).
Suppressor T cells are known to suppress the action of other
immune cells, most notably B-cells and T-cells, and thereby
prevent the establishment of an immune response. Helper
T cells act on other cells in the immune system to promote
various aspects of immune response, including immunoglob-
ulin isotype switching and affinity maturation of antibody
response, macrophage activation, and the enhanced activity
of NK cells and cytotoxic T cells (22). Thus, a reduction in
the Ts cell proportion and an elevation of the Th/Ts ratio may
reflect altered immunity, which suggests a possibility of T cell
activation in panic disorder. Thus, examining the functional
measures of T cell activation will be needed in a future study.
Some panic patients in this study had more depressive fea-
tures (HAMD score >17), even though they did not meet
the major depressive disorder DSM-IV criteria. Indeed, both
panic disorder and major depressive disorders are highly co-
morbid and are probably affected by the same serotonin and
norepinephrine neurotransmitter systems (23). However, pa-
tients with panic disorder are known to have immune find-
ings that differ from those with major depression (6, 7). More-
over, the depressive symptoms of panic disorder patients were
not found to affect any enumerative immune variables, except
for NK cell proportion in this study. Thus, a depressed mood
per se does not seem to play an important role in altered mea-
sures of immunity in panic disorder patients.
With regard to stress, a reduction in the number of lympho-
cytes and a suppression of lymphocyte proliferative response
to mitogen were demonstrated by a psychiatric fellowship
examination (24). Speech stress in healthy men was found to
result in significant increases in Ts cells and NK cells and a
reduction in the Th/Ts ratio versus baseline (25). Gerritsen
and colleagues (26) also found that a laboratory induced fear
situation (public speaking) produced changes in the experi-
mental subjects’ immune systems, and specifically reduced
the numbers of Th cells and T lymphocytes. Heightened stress
as well as heritable factors has been suggested to contribute
to the onset of panic disorder (27). Although a panic attack
itself can also be a severe stressor, previous findings described
the above seem to be at odds with ours, even though we did
not directly measure stress levels in this study. In the present
study, we tried as much as possible to reduce the effects of
acute stress on lymphocyte subsets during the experimental
procedures. Thus, our findings concerning lymphocyte sub-
sets are more likely to be related to panic disorder itself, and
not stress per se.
Multiple regression analyses revealed that anxiety levels in
panic disorder patients correlated positively with T cell num-
ber and proportion, and Th cell number, but anxiety levels
were found to be negatively correlated with NK cell propor-
tion in the present study. Weizman (28) reported that inter-
leukin 3 (IL3) production is negatively correlated with the
Variable t p Value
Control subjects
N=20 (Male=10)
Mean SD
Panic patients
N=20 (Male=10)
Mean SD
Total WBC 5400.0 1245.6 6475.0 2284.9 -1.85 0.072
Lymphocyte No. 2017.8 504.0 2082.5 544.8 -0.39 0.699
Lymphocyte % 37.9 7.1 33.6 7.5 1.88 0.068
CD3 T cell No. 1444.2 464.2 1469.5 436.1 -0.18 0.860
CD3 T cell % 70.8 7.4 70.2 8.5 0.22 0.824
CD4 Th cell No. 778.0 303.2 861.8 217.5 -1.09 0.283
CD4 Th cell % 37.9 8.4 42.3 7.8 -1.74 0.090
CD8 Ts cell No. 626.1 228.0 553.5 225.8 1.01 0.318
CD8 Ts cell % 30.8 6.7 25.7 5.6 2.63 0.012*
CD4/CD8 ratio 1.3 0.5 1.8 0.6 -2.57 0.014*
CD16 NK cell No. 274.6 123.6 332.6 184.1 -1.17 0.250
CD16 NK cell % 14.2 6.6 16.1 8.0 -0.81 0.422
CD19 B cell No. 299.0 92.0 280.4 102.5 0.60 0.550
CD19 B cell % 15.0 3.2 13.7 4.0 1.13 0.264
Table 2. Immune measures in panic patients and control subjects
WBC, White blood cell; Th cell, T helper cell; Ts cell, T suppressor cell;
NK cell, Natural killer cell.
*, p<0.05.
Outcome
factor
Good
predictors
t p R
2
CD3 No. HAMA 0.544 2.594 0.020 0.296
CD3 % STAIS 0.533 2.517 0.023 0.284
CD4 No. HAMA 0.480 2.188 0.044 0.230
CD16 % HAMA -0.493 -2.266 0.038 0.243
Table 3. Predictive variables for immune changes in panic pati-
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severity of anxiety, and that IL3 might be sensitive to the pres-
ence of anxiety. Hence, our findings also support that anxiety
levels in panic disorder patients could affect immunity, alth-
ough the mechanism and meaning of altered immunity in
panic disorder remain unknown.
Several limitations of our study should be noted. First, the
sample size in our study was relatively small, although there
were very few immune studies with a large sample size in panic
disorder. Second, there is a possibility that panic disorder pa-
tients with severe symptoms might have been excluded be-
cause the patients in this study had a relatively recent illness
onset and did not take any regular medication at the time of
study commencement. Third, our study was limited to enu-
merative immune measures, although recent immunological
studies have included other functional immune measures, such
as mitogen induced lymphocyte proliferation and NK cell
cytotoxicity, as well as enumerative measures. In addition,
the result of increased Th/Ts ratio in this study differed from
that of our recent study (29), which showed no significant
difference in Th/Ts ratio between panic disorder patients and
normal control subjects. It is difficult to explain why this dif-
ference occurred, but one possible explanation would be that
panic patients with different anxiety levels were involved in
each study. Thus, in the future, a prospective study with a
lager sample size using functional immune measures, as well
as enumerative ones, will be needed to confirm the contradic-
tory immune finding in panic disorder.
In conclusion, panic disorder patients showed a reduced Ts
cell proportion and an increased Th/Ts ratio. Moreover, higher
levels of anxiety were found to be related to an altered T cell
population in panic disorder patients. Quantitative immune
differences may reflect altered immunity in panic disorder.
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